Pro‐inflammatory cytokines (IL‐6, IL‐8, TNF‐α) and anti‐inflammatory cytokines (IL‐1RA, IL‐1R2) have been shown to be prospectively associated with increased lung cancer risk (Mario, Giovanny, Pedro, Norma, & Oscar, 2016). This evidence concerns the gene IL1R2 and lung carcinoma.